Pharming Group Company Profile (NASDAQ:PHGUF)

About Pharming Group (NASDAQ:PHGUF)

Pharming Group logoPharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company's products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming's technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company's commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PHGUF
  • CUSIP: N/A
  • Web:
Average Prices:
  • 52 Week Range: $0.18 - $0.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 12.09
  • P/E Growth: 0.0000
Sales & Book Value:
  • Annual Revenue: $17.31 million
  • Price / Sales: N/A
  • Book Value: $0.07 per share
  • Price / Book: 5.49
  • EBIDTA: ($11,820,000.00)

Frequently Asked Questions for Pharming Group (NASDAQ:PHGUF)

What is Pharming Group's stock symbol?

Pharming Group trades on the NASDAQ under the ticker symbol "PHGUF."

How were Pharming Group's earnings last quarter?

Pharming Group (NASDAQ:PHGUF) released its quarterly earnings data on Thursday, March, 5th. The company reported $0.05 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.04 by $0.01. View Pharming Group's Earnings History.

Who are some of Pharming Group's key competitors?

How do I buy Pharming Group stock?

Shares of Pharming Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Pharming Group stock cost?

One share of Pharming Group stock can currently be purchased for approximately $0.36.

Analyst Ratings

Consensus Ratings for Pharming Group (NASDAQ:PHGUF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Pharming Group (NASDAQ:PHGUF)
No equities research coverage for this company has been tracked by


Earnings History for Pharming Group (NASDAQ:PHGUF)
Earnings by Quarter for Pharming Group (NASDAQ:PHGUF)
Earnings History by Quarter for Pharming Group (NASDAQ:PHGUF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/5/2015$0.04$0.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Pharming Group (NASDAQ:PHGUF)
Current Year EPS Consensus Estimate: $-0.0300 EPS
Next Year EPS Consensus Estimate: $0.0300 EPS


Dividend History for Pharming Group (NASDAQ:PHGUF)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Pharming Group (NASDAQ:PHGUF)
No insider trades for this company have been tracked by


Headline Trends for Pharming Group (NASDAQ:PHGUF)
Latest Headlines for Pharming Group (NASDAQ:PHGUF)
DateHeadline logoZacks: Pharming Group (PHGUF) Receives Consensus Rating of "" from Brokerages - March 29 at 12:19 PM logoPharming Group Expected to Post Q3 2017 Earnings of $0.00 Per Share (PHGUF) - March 13 at 11:38 AM logoPharming Bets The House On Ruconest - November 24 at 10:11 AM logoPharming Bets The House On Ruconest - Seeking Alpha - November 23 at 10:01 AM logoA European Biotech Stock Basket For 2016 - Seeking Alpha - January 27 at 11:43 AM



Pharming Group (PHGUF) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff